Skip to content Skip to sidebar Skip to footer

GlaxoSmithKline (GSK)

HomeAll PostsGlaxoSmithKline (GSK)

GlaxoSmithKline taps Baltimore’s Insilico for AI-based drug discovery

GlaxoSmithKline (GSK)16 August 201790Views 0Likes 0Comments

GlaxoSmithKline and Insilico Medicine are partnering to explore how the latter’s artificial intelligence technology c | GlaxoSmithKline and Insilico Medicine are partnering to explore how the latter’s artificial intelligence technology can aid in the drug discovery process.